 (NA24) Antibody) Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC552053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC612053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC612053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC402053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC402053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC472053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC472053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC052053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC052053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC042053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC042053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC432053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC432053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNUB2053-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Concentration: 0.2mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNUB2053-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), 1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNUB2053-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Concentration: 0.2mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC682053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC682053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC702053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC702053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC882053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC882053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC942053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC942053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCB2053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCB2053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCH2053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCH2053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC802053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC802053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCP2053-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCR2053-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), RPE conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCA2053-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), APC conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCAP2053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNCAP2053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC812053-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24) Antibody |
|||
| BNC812053-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF680R conjugate, Concentration: 0.1mg/mL |
|||
 (HuLy-m2) Antibody) CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC551252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC551252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF555 conjugate, Concentration: 0.1mg/mL |
|||
 (ZAP70/2035) Antibody) ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC552035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC552035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL |
|||
 (ZAP70/2046) Antibody) ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC552046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC552046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC611252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC611252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC612035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC612035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC612046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC612046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC401252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC401252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF640R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC402035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC402035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC402046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC402046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC431252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC431252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC471252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC471252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF647 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC472035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC472035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC472046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC472046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC051252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC051252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC052035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC052035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC052046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC052046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC041252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC041252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405S conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC042035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC042035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC042046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC042046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC432035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC432035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC432046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC432046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNUB1252-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), Concentration: 0.2mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNUB1252-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), Concentration: 0.2mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNUB2035-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNUB2035-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNUB2035-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNUB2046-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNUB2046-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNUB2046-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNUM1252-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), 1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC681252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC681252-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF568 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC682035-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|||
| BNC682035-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC682046-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL |
|||
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|||
| BNC682046-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD7 (T-Cell Leukemia Marker) (HuLy-m2) Antibody |
|||
| BNC701252-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF770 conjugate, Concentration: 0.1mg/mL |
|||